Clinical Trial Update: Effects of IL-1 Beta on the HPA-axis in Obese Persons [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effects of interleukin-1 beta on the HPA axis in obese individuals has completed. It relates to metabolic syndrome and cortisol hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome
• Metabolic Syndrome

Drugs mentioned

• Interleukin-1 beta (interleukin-1 beta)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Metabolic Syndrome, Hypersecretion; Cortisol | Phase 3 | Status: COMPLETED